Teleflex
TFX | NYSE
$140.30
+$0.53 (+0.38%)
Nov 2, 2026, 9:30 AM ET · Market open
Company Profile
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Key Executives
| Name | Position |
|---|---|
| Jason Weidman | President, CEO & Director |
| John R. Deren | Executive Vice President & Chief Financial Officer |
| Timothy F. Duffy | Vice President & Chief Information Officer |
| Cameron Hicks | Corporate Vice President of Human Resources & Communications |
| Daniel V. Logue | Corporate Vice President, General Counsel & Secretary |
| Howard Cyr | Corporate Vice President & Chief Compliance Officer |
| Jake Newman | President & GM of Vascular and Emergency Medicine |
| James Ferguson | President & GM of Surgical |
| Lawrence Soren Keusch | Vice President of Investor Relations & Strategy Development |
| Matt Tomkin | Vice President of Corporate Development |
| Matthew James | President & GM of Interventional |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 10, 2026 | 4 | Filing |
| Sep 10, 2026 | 3 | Filing |
| Sep 09, 2026 | 8-K | Current Report |
| Sep 08, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 07, 2026 | 8-K | Current Report |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Aug 05, 2026 | 8-K/A | [Amend] Current Report |
| Aug 03, 2026 | 8-K | Current Report |
Teleflex
| Country | United States |
| IPO Date | Mar 17, 1980 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 15,500 |
| CEO | Jason Weidman |
Contact Details
550 East Swedesford Road Wayne,
Pennsylvania 19087-1603 United States
Stock Details
| Ticker Symbol | TFX |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000096943 |
| CUSIP Number | 879369106 |
| ISIN Number | US8793691069 |
| SIC Code | 3841 |
Recent News
- 11 days ago / businesswire.comTeleflex Announces Third Quarter 2026 Earnings Conference Call Information
- 21 days ago / businesswire.comEnrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
- 27 days ago / zacks.comTFX or SONVY: Which Is the Better Value Stock Right Now?
- 27 days ago / zacks.comIs It Prudent to Add Teleflex Stock to Your Portfolio Now?
- 1 month ago / businesswire.comTeleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology
- 1 month ago / zacks.comTeleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?
- 2 months ago / zacks.comHere's Why Teleflex (TFX) is a Strong Value Stock
- 2 months ago / zacks.comTFX vs. PEN: Which Stock Is the Better Value Option?
- 2 months ago / businesswire.comTeleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
- 2 months ago / businesswire.comTeleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026
Add to Watchlist
Select watchlists to add or remove TFX